UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Central Pacific Financial
CPF
$1B
| $656K | ﹤0.01% |
36,646
+2,060
| +6% | +$43.9K |
|
2152
Arcutis Biotherapeutics
ARQT
$3.18B
| $656K | ﹤0.01% |
59,615
+25,899
| +77% | +$375K |
|
2153
Center Bancorp
CNOB
$1.78B
| $656K | ﹤0.01% |
37,085
+3,547
| +11% | +$80.8K |
|
2154
GeoPark
GPRK
$612M
| $655K | ﹤0.01% |
57,615
-10,100
| -15% | -$134K |
|
2155
Amerant Bancorp
AMTB
$1.13B
| $653K | ﹤0.01% |
+29,997
| New | +$798K |
|
|
ARR
2156
Armour Residential REIT
ARR
$2.36B
| $652K | ﹤0.01% |
+24,841
| New | +$702K |
|
2157
Lemonade
LMND
$4.1B
| $650K | ﹤0.01% |
+45,611
| New | +$693K |
|
2158
Titan Machinery
TITN
$445M
| $650K | ﹤0.01% |
21,359
+6,016
| +39% | +$245K |
|
2159
Adeia
ADEA
$3.11B
| $649K | ﹤0.01% |
73,256
-20,138
| -22% | -$201K |
|
|
CHUY
2160
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $648K | ﹤0.01% |
18,081
| – | – |
|
|
VSTO
2161
DELISTED
Vista Outdoor Inc.
VSTO
| $648K | ﹤0.01% |
23,392
+1,080
| +5% | +$29.6K |
|
2162
Opko Health
OPK
$1.02B
| $643K | ﹤0.01% |
440,282
+106,211
| +32% | +$137K |
|
2163
FB Financial Corp
FBK
$3.04B
| $642K | ﹤0.01% |
20,663
-7,900
| -28% | -$282K |
|
|
FARO
2164
DELISTED
Faro Technologies
FARO
| $640K | ﹤0.01% |
25,986
+1,812
| +7% | +$50.3K |
|
|
FPI
2165
Farmland Partners
FPI
$432M
| $636K | ﹤0.01% |
59,436
+5,724
| +11% | +$67K |
|
|
ARCH
2166
DELISTED
Arch Resources, Inc.
ARCH
| $635K | ﹤0.01% |
4,829
-964
| -17% | -$139K |
|
2167
CEVA Inc
CEVA
$1.08B
| $630K | ﹤0.01% |
20,707
+2,217
| +12% | +$69.4K |
|
2168
Genco Shipping & Trading
GNK
$1.1B
| $626K | ﹤0.01% |
39,964
-1,685
| -4% | -$28.9K |
|
2169
First Financial Corp
THFF
$969M
| $626K | ﹤0.01% |
16,692
+1,404
| +9% | +$60.3K |
|
2170
Globalstar
GSAT
$10.8B
| $622K | ﹤0.01% |
35,768
-18,291
| -34% | -$337K |
|
|
CVGW
2171
DELISTED
Calavo Growers
CVGW
| $622K | ﹤0.01% |
21,616
| – | – |
|
2172
Genesco
GCO
$422M
| $621K | ﹤0.01% |
16,833
+1,505
| +10% | +$65.9K |
|
2173
E.W. Scripps
SSP
$304M
| $620K | ﹤0.01% |
65,865
| – | – |
|
|
RDFN
2174
DELISTED
Redfin
RDFN
| $618K | ﹤0.01% |
68,206
+17,199
| +34% | +$128K |
|
|
VTYX
2175
DELISTED
Ventyx Biosciences
VTYX
| $616K | ﹤0.01% |
18,400
+3,100
| +20% | +$121K |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.